Company Overview
GoHealth, Inc. functions as a specialized health insurance marketplace and a Medicare-focused digital health entity operating within the United States. The company leverages a proprietary technology platform that utilizes machine-learning algorithms to analyze insurance purchasing behavior and optimize the process of matching individuals with appropriate health plans. This business model places the company firmly within the Financial Services sector, specifically the Insurance Brokers industry, where it facilitates the distribution of health coverage while employing advanced data analytics. The organization maintains a significant operational footprint with 2,261 employees supporting its digital infrastructure and brokerage operations. Its market capitalization stands at $44.65 million, while its trailing twelve-month revenue totals $738.34 million. These valuation and revenue figures indicate a company that generates substantial top-line volume despite its current market cap reflecting a distinct disparity between its earnings performance and its public valuation. The scale of its operations suggests a focus on high-volume, low-margin brokerage activities typical of digital-first insurance platforms.
Financial Health
GoHealth reported a trailing twelve-month revenue of $738.34 million, yet this figure is accompanied by a net income loss of $202,878,000 and an EBITDA of $58.72 million. The substantial gap between the $738.34 million revenue and the negative $202,878,000 net income reveals a cost structure where operating expenses significantly exceed gross profits, resulting in an operating margin of -239.1%. A gross margin of 80.5% indicates that the company retains a high portion of revenue after direct costs, but the extremely negative operating margin suggests that overhead, technology, or acquisition costs are consuming the majority of those gross profits. Despite the net loss, the company generated positive free cash flow of $43.85 million, which provides a degree of financial flexibility to fund operations or strategic initiatives without immediate reliance on external financing. However, the balance sheet carries a total debt load of $616.72 million against cash holdings of $32.08 million, resulting in a debt-to-equity ratio of 1259.33. This leverage ratio indicates a highly leveraged balance sheet where debt obligations are substantial relative to shareholder equity. The current ratio of 1.64 suggests that the company holds sufficient current assets to cover its short-term liabilities, indicating a baseline level of short-term liquidity. Furthermore, the return on equity is -171.1% and the return on assets is -2.1%, metrics that reveal that management has not yet been effective in generating positive returns on the capital invested in the business during the reporting period.
Valuation Assessment
The valuation metrics for GoHealth present a complex picture, with a trailing P/E ratio listed as N/A and a forward P/E of -0.40. The difference between a non-existent trailing P/E and a negative forward P/E implies that the market is pricing in expected earnings contraction or that future earnings are projected to remain negative, preventing a standard earnings-based valuation. The price-to-book ratio is 0.37, which indicates that the market values the company at a fraction of its book value, suggesting a lack of premium over tangible assets. Alternative valuation metrics such as a price-to-sales ratio of 0.06 and an EV/EBITDA of 10.06 provide different perspectives; the low multiple on sales suggests the stock trades at a discount relative to its revenue generation, while the EV/EBITDA indicates enterprise value relative to cash flow before interest, taxes, depreciation, and amortization. The stock price has experienced significant volatility, with a 52-week high of $13.95 and a 52-week low of $1.31. Based on the provided data, the current trading range sits somewhere between these extremes, reflecting the severe price depreciation from the yearly high. The beta value of 1.73 indicates that the stock price is significantly more volatile than the broader market, moving with greater intensity than the general equity index.
Growth & Income
GoHealth experienced a revenue growth rate of -71.1% year-over-year, while earnings growth is listed as N/A due to the current net loss position. The absence of positive earnings growth alongside negative revenue growth implies that the company is currently contracting in both top-line sales and profitability, with no immediate trajectory toward earnings recovery visible in the provided data. As a non-dividend payer, the company has a dividend yield of N/A and a payout ratio of 0.0%, meaning it does not distribute cash to shareholders and instead retains any generated cash flow for internal use. This reinvestment approach is typical for companies in a turnaround phase or those with negative earnings that require capital preservation rather than shareholder distributions. The overall growth and income profile is characterized by a contraction in revenue, a lack of dividends, and a reliance on cash flow generation to support a highly leveraged balance sheet in the absence of profit.